EUVIMEDEUVIMED entdecken
Crossref

LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells

Mi Zhang, Siyu Liu, Chenyang Fu, Xusu Wang, Min Zhang, Guangquan Liu, Chencheng Dai, Zhen Gong, Hanzi Xu, Ziyi Fu, Pengfei Xu, Juan Xu und 1 weitere

Cancer Biotherapy and Radiopharmaceuticals · 2019-06 · 34 (5) · 316-324

DOI: 10.1089/cbr.2018.2698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2019-06. Verfasst von Mi Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Gynecology, Women's Hospital of Nanjing Medical University (Nanjing Maternity and Child Health Care Hospital), Nanjing, China. Hauptthemen laut MEDLINE: Cell Movement, Cell Proliferation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell MovementCell ProliferationGene Expression Regulation, NeoplasticAntineoplastic Agents, PhytogenicApoptosisCystadenocarcinoma, SerousDrug Resistance, NeoplasmFemaleHumansMiddle AgedOvarian NeoplasmsPaclitaxelPrognosisRNA, Long NoncodingTumor Cells, Cultured

Stichwörter der Autor:innen

KB-1471A8.2migrationovarian cancerpaclitaxel resistanceproliferation

Substanzen

Antineoplastic Agents, PhytogenicRNA, Long NoncodingPaclitaxel

Autor:innen und Institutionen

  • 1 Department of Gynecology, Women's Hospital of Nanjing Medical University (Nanjing Maternity and Child Health Care Hospital), Nanjing, China.
  • 2 Department of Gynecology, Jiangyin Maternity and Child Health Care Hospital, Jiangyin, China.
  • 3 Department of Gynecology, Gannan Medical University, Ganzhou, China.
  • 4 Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing, China.
  • 5 Nanjing Maternity and Child Health Medical Institute, Women's Hospital of Nanjing Medical University (Nanjing Maternity and Child Health Care Hospital), Nanjing, China.

Zitieren

APA

Zhang, M., Liu, S., Fu, C., Wang, X., Zhang, M., Liu, G., Dai, C., Gong, Z., Xu, H., Fu, Z., Xu, P., Xu, J., & Jia, X. (2019). LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals, 34(5), 316-324. https://doi.org/10.1089/cbr.2018.2698

Vancouver

Zhang M, Liu S, Fu C, Wang X, Zhang M, Liu G, et al. LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals. 2019;34(5):316-324. doi:10.1089/cbr.2018.2698

BibTeX
@article{Zhang2019,
  author = {Zhang, Mi and Liu, Siyu and Fu, Chenyang and Wang, Xusu and Zhang, Min and Liu, Guangquan and Dai, Chencheng and Gong, Zhen and Xu, Hanzi and Fu, Ziyi and Xu, Pengfei and Xu, Juan and Jia, Xuemei},
  title = {LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2019},
  volume = {34},
  number = {5},
  pages = {316--324},
  doi = {10.1089/cbr.2018.2698}
}
Kostenlos starten →